Results :
Combined therapy after 1 month follow-up, achieved an improvement in BCVA of 0.12 logMAR , with a reduction of 407 microns to 366 microns in central macular thickness (CMT), a reduction on macular volume of 10.32 to 9.82 mm3 being an average of 0.5 mm3 after the first month of treatment, being similar at 3 months of follow up and statistically significant. (p< 0.05)